1. |
Suster S, Moran CA. Thymoma classification current status and future trends[J]. Am J Clin Pathol, 2006, 125(4): 542-554. DOI: 10.1309/CAV8-RNU5-TKNA-CKNC.
|
2. |
RA G. Agammaglobulinemia: a provocative experiment of nature[J]. Bull Univ Minn Hosp, 1954, 26: 1-19.
|
3. |
Multani A, Gomez CA, Montoya JG. Prevention of infectious diseases in patients with Good syndrome[J]. Curr Opin Infect Dis, 2018, 31(4): 267-277. DOI: 10.1097/QCO.0000000000000473.
|
4. |
Paranavitane S, Handagala S, De Silva R, et al. Thymoma complicated with myasthenia gravis and Good syndrome-a therapeutic conundrum: a case report[J]. J Med Case Rep, 2019, 13(1): 348. DOI: 10.1186/s13256-019-2289-z.
|
5. |
Inomata T, Honda M, Murakami A. Atypical VZV retinitis in a patient with good syndrome[J]. Ocul Immunol Inflamm, 2018, 26(2): 194-198. DOI: 10.1080/09273948.2016.1201518.
|
6. |
Tarr PE, Sneller MC, Mechanic LJ, et al. Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature[J]. Medicine (Baltimore), 2001, 80(2): 123-133. DOI: 10.1097/00005792-200103000-00005.
|
7. |
Assi AC, Lightman S. Clinicopathologic reports, case reports, and small case series: cytomegalovirus retinitis in patients with Good syndrome[J]. Arch Ophthalmol, 2002, 120(4): 510-512.
|
8. |
Sen HN, Robinson MR, Fischer SH. CMV retinitis in a patient with good syndrome[J]. Ocul Immunol Inflamm, 2005, 13(6): 475-478. DOI: 10.1080/09273940590950963.
|
9. |
Yong DS, Tsang MK, Chan EY, et al. Good's syndrome in a patient with cytomegalovirus retinitis[J]. Hong Kong Med J, 2008, 14(2): 142-144.
|
10. |
Popiela M, Varikkara M, Koshy Z. Cytomegalovirus retinitis in Good syndrome: case report and review of literature[J/OL]. BMJ Case Rep, 2009, 2009: bcr02.2009. 1576[2009-06-21]. https://pubmed.ncbi.nlm.nih.gov/21691402/. DOI: 10.1136/bcr.02.2009.1576.
|
11. |
Ho JK, Wong MM, Tai TK, et al. A rare combination of recurrent pneumonia, diarrhoea, and visual loss in a patient after thymectomy good syndrome[J]. Hong Kong Med J, 2010, 16(6): 493-496.
|
12. |
Mateo-Montoya A, Stanescu D, Wolff B, et al. Cytomegalovirus retinitis associated with Good's syndrome[J]. Eur J Ophthalmol, 2010, 20(2): 479-480. DOI: 10.1177/112067211002000238.
|
13. |
Park DH, Kim SY, Shin JP. Bilateral cytomegalovirus retinitis with unilateral optic neuritis in Good syndrome[J]. Jpn J Ophthalmol, 2010, 54(3): 246-248. DOI: 10.1007/s10384-009-0795-z.
|
14. |
Wan CK, Teoh SC. Autoimmune retinopathy in benign thymoma after good syndrome-associated cytomegalovirus retinitis[J]. Ocul Immunol Inflamm, 2013, 21(1): 64-66. DOI: 10.3109/09273948.2012.730652.
|
15. |
Downes KM, Tarasewicz D, Weisberg LJ, et al. Good syndrome and other causes of cytomegalovirus retinitis in HIV-negative patients-case report and comprehensive review of the literature[J]. J Ophthalmic Inflamm Infect, 2016, 6(1): 3. DOI: 10.1186/s12348-016-0070-7.
|
16. |
Lee SW, Lee YW, Bae JH. Cytomegalovirus retinitis as the first manifestation of Good syndrome[J]. Ocul Immunol Inflamm, 2016, 26(1): 122-124. DOI: 10.1080/09273948.2016.1199713.
|
17. |
Hu F, Du Y, Peng XY. Successively bilateral cytomegalovirus retinitis in immunocompromised patient with Good's syndrome[J]. Int J Ophthalmol, 2018, 11(12): 2021-2023. DOI: 10.18240/ijo.2018.12.24.
|
18. |
Karkhaneh R, Lashay A, Ahmadraji A. Cytomegalovirus retinitis in an immunocompetent patient: a case report[J]. J Curr Ophthalmol, 2016, 28(2): 93-95. DOI: 10.1016/j.joco.2015.12.003.
|
19. |
Port AD, Orlin A, Kiss S, et al. Cytomegalovirus retinitis: a review[J]. J Ocul Pharmacol Ther, 2017, 33(4): 224-234. DOI: 10.1089/jop.2016.0140.
|
20. |
Martin DF, Sierra-Madero J, Walmsley S, et al. A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis[J]. N Engl J Med, 2002, 346(15): 1119-1126. DOI: 10.1056/NEJMoa011759.
|
21. |
Shapira Y, Mimouni M, Vishnevskia-Dai V. Cytomegalovirus retinitis in HIV-negative patients - associated conditions, clinical presentation, diagnostic methods and treatment strategy[J/OL]. Acta ophthalmologica, 2018, 96(7): e761-e767[2017-10-25]. https://pubmed.ncbi.nlm.nih.gov/29068151/. DOI: 10.1111/aos.13553.
|
22. |
Cunningham ET Jr, Hubbard LD, Danis RP, et al. Proportionate topographic areas of retinal zones 1, 2, and 3 for use in describing infectious retinitis[J]. Arch Ophthalmol, 2011, 129(11): 1507-1508. DOI: 10.1001/archophthalmol.2011.331.
|